Key Events This Week
13 Jul: Stock opens at Rs.1,007.45, marginally down -0.04%
14 Jul: New 52-week high at Rs.1,104.15 and intraday surge of 7.13%
15 Jul: Further 52-week high at Rs.1,114.6 with 4.60% daily gain
16 Jul: New 52-week high at Rs.1,120, slight pullback of -1.61%
17 Jul: Week closes at Rs.1,041.55, down -3.73% on day but up 3.34% for week

Orchid Pharma Ltd is Rated Sell
2026-07-18 10:10:06Orchid Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 1120
2026-07-16 09:50:25Surging past the Rs 1120 mark on 16 Jul 2026, Orchid Pharma Ltd has reached a fresh 52-week high, extending its impressive 45.84% gain over the past year. This milestone comes amid a backdrop of robust technical momentum and a market environment where the Sensex trades modestly higher, underscoring the stock’s standout performance within the Pharmaceuticals & Biotechnology sector.
Read full news article
Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 1114.6
2026-07-15 11:35:55Surging past Rs 1114.6 on 15 Jul 2026, Orchid Pharma Ltd has marked a significant milestone by reaching a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum.
Read full news article










